JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 2, 2003; DOI: 10.1124/jpet.103.051284


0022-3565/03/3062-718-725$20.00
JPET 306:718-725, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.051284v1
306/2/718    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayashi, T.
Right arrow Articles by Su, T.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayashi, T.
Right arrow Articles by Su, T.-P.

NEUROPHARMACOLOGY

{sigma}-1 Receptors ({sigma}1 Binding Sites) Form Raft-Like Microdomains and Target Lipid Droplets on the Endoplasmic Reticulum: Roles in Endoplasmic Reticulum Lipid Compartmentalization and Export

Teruo Hayashi, and Tsung-Ping Su

Cellular Pathobiology Unit, Cellular Neurobiology Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health. Department of Health and Human Services, Baltimore, Maryland

The brain {sigma}-1 receptors can bind neurosteroids and psychotropic drugs, including neuroleptics and cocaine and are implicated in schizophrenia, depression, and drug dependence. In this study, we found that {sigma}-1 receptors specifically target lipid storage sites (lipid droplets) on the endoplasmic reticulum by forming a distinct class of lipid microdomains. Both endogenously expressing {sigma}-1 receptors and transfected C-terminally enhanced yellow fluorescent protein (EYFP)-tagged {sigma}-1 receptors (Sig-1R-EYFP) target unique "ring-like" structures associated with endoplasmic reticulum reticular networks in NG108-15 cells. The ring-like structures contain neutral lipids and are enlarged by the oleate treatment, indicating that they are endoplasmic reticulum-associated lipid droplets (ER-LDs). {sigma}-1 receptors colocalize with caveolin-2, a cholesterol-binding protein in lipid rafts on the ER-LDs, but not with adipocyte differentiation-related protein (ADRP), a cytosolic lipid droplet (c-LD)-specific protein. When the double-arginine ER retention signal on the N terminus of {sigma}-1 receptors is truncated, {sigma}-1 receptors no longer exist on ER-LDs, but predominantly target c-LDs, which contain ADRP. {sigma}-1 receptors on ER-LDs form detergent-resistant raft-like lipid microdomains, the buoyancy of which is different from that of plasma membrane lipid rafts. (+)-Pentazocine causes {sigma}-1 receptors to disappear from the microdomains. N-Terminally EYFP-tagged {sigma}-1 receptors (EYFP-Sig-1R) failed to target ER-LDs. EYFP-Sig-1R-transfected cells showed an unrestricted distribution of neutral lipids all over the endoplasmic reticulum network, decreases in c-LDs and cholesterol in plasma membranes, and the bulbous aggregation of endoplasmic reticulum. Thus, {sigma}-1 receptors are unique endoplasmic reticulum proteins that regulate the compartmentalization of lipids on the endoplasmic reticulum and their export from the endoplasmic reticulum to plasma membrane and c-LDs.


Received for publication March 5, 2003
Accepted April 29, 2003.

Address correspondence to: Dr. Tsung-Ping Su, Cellular Pathobiology Unit, Cellular Neurobiology Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, 5500 Nathan Shock Dr., Baltimore, MD 21224. E-mail: tsu{at}intra.nida.nih.gov




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Pal, U. B. Chu, S. Ramachandran, D. Grawoig, L.-W. Guo, A. R. Hajipour, and A. E. Ruoho
Juxtaposition of the Steroid Binding Domain-like I and II Regions Constitutes a Ligand Binding Site in the {sigma}-1 Receptor
J. Biol. Chem., July 11, 2008; 283(28): 19646 - 19656.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. T. Tchedre and T. Yorio
{sigma}-1 Receptors Protect RGC-5 Cells from Apoptosis by Regulating Intracellular Calcium, Bax Levels, and Caspase-3 Activation
Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2577 - 2588.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. P. Palmer, R. Mahen, E. Schnell, M. B.A. Djamgoz, and E. Aydar
Sigma-1 Receptors Bind Cholesterol and Remodel Lipid Rafts in Breast Cancer Cell Lines
Cancer Res., December 1, 2007; 67(23): 11166 - 11175.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Pal, A. R. Hajipour, D. Fontanilla, S. Ramachandran, U. B. Chu, T. Mavlyutov, and A. E. Ruoho
Identification of Regions of the {sigma}-1 Receptor Ligand Binding Site Using a Novel Photoprobe
Mol. Pharmacol., October 1, 2007; 72(4): 921 - 933.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Cormaci, T. Mori, T. Hayashi, and T.-P. Su
Protein Kinase A Activation Down-Regulates, Whereas Extracellular Signal-Regulated Kinase Activation Up-Regulates {sigma}-1 Receptors in B-104 Cells: Implication for Neuroplasticity
J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 202 - 210.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D. T. Browman, M. E. Resek, L. D. Zajchowski, and S. M. Robbins
Erlin-1 and erlin-2 are novel members of the prohibitin family of proteins that define lipid-raft-like domains of the ER
J. Cell Sci., August 1, 2006; 119(15): 3149 - 3160.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. Azzariti, N. A. Colabufo, F. Berardi, L. Porcelli, M. Niso, G. M. Simone, R. Perrone, and A. Paradiso
Cyclohexylpiperazine derivative PB28, a {sigma}2 agonist and {sigma}1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer.
Mol. Cancer Ther., July 1, 2006; 5(7): 1807 - 1816.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Yagasaki, T. Numakawa, E. Kumamaru, T. Hayashi, T.-P. Su, and H. Kunugi
Chronic Antidepressants Potentiate via Sigma-1 Receptors the Brain-derived Neurotrophic Factor-induced Signaling for Glutamate Release
J. Biol. Chem., May 5, 2006; 281(18): 12941 - 12949.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
W. E. Ackerman IV, J. M. Robinson, and D. A. Kniss
Despite Transcriptional and Functional Coordination, Cyclooxygenase-2 and Microsomal Prostaglandin E Synthase-1 Largely Reside in Distinct Lipid Microdomains in WISH Epithelial Cells
J. Histochem. Cytochem., November 1, 2005; 53(11): 1391 - 1401.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Ozeki, J. Cheng, K. Tauchi-Sato, N. Hatano, H. Taniguchi, and T. Fujimoto
Rab18 localizes to lipid droplets and induces their close apposition to the endoplasmic reticulum-derived membrane
J. Cell Sci., June 15, 2005; 118(12): 2601 - 2611.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Hayashi and T.-P. Su
Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation
PNAS, October 12, 2004; 101(41): 14949 - 14954.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Aydar, C. P. Palmer, and M. B. A. Djamgoz
Sigma Receptors and Cancer: Possible Involvement of Ion Channels
Cancer Res., August 1, 2004; 64(15): 5029 - 5035.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Hayashi and T.-P. Su
Intracellular Dynamics of {sigma}-1 Receptors ({sigma}1 Binding Sites) in NG108-15 Cells
J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 726 - 733.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.